Investigators reported the development of a novel CD46-targeted alpha therapy based on the internalizing human monoclonal antibody, YS5.
[Journal Of Experimental & Clinical Cancer Research]
Home Newsletters CD46 Targeted 212Pb Alpha Particle Radioimmunotherapy for Prostate Cancer Treatment
